Croda's RNS - new Broker and raising cash...6 Jun 2025 10:02
This mornings RNS from CRODA..
I'm not a financial whizz (as most of you know) so I asked chatgpt:
Via ChatGPT (re CRODAs RNS this morning)
Could they use it for SBTX?
Yes, theoretically:
Buying SBTX would give Croda full control of Zenakine, capture royalties, and reduce licensing fees.
Theyβve signaled interest in rolling up related businesses (SBTX itself notes acquisition activity in its RNS)
BUT (Also via chatGPT)
So is it likely?
Unclear and speculative, for these reasons:
No official indication: Todayβs placing likely cites capacity investment, not M&A.
Price mismatch: Funding SBTXβs current market cap (~Β£50β―m) wouldnβt move the needle materially relative to Crodaβs Β£3β―bn+ valuation.
Regulatory complexity: Acquiring an AIM-listed biotech requires governance, pre-emption, and transparency stepsβmore than a single broker move.